ResearcherAffiliated Hospital of Qingdao UniversityNo recent work listed

Guanglan Wang

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2017: 1 paper

Papers 1

MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of pancreatic cancer. Last author DOI 10.3892/etm.2017.4770 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaoyu Li · 1 shared paper, 2017 · strength 0.06
- Paper MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of… DOI 10.3892/etm.2017.4770 ↗
Zibin Tian · 1 shared paper, 2017 · strength 0.06
- Paper MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of… DOI 10.3892/etm.2017.4770 ↗
Cuiping Zhang · 1 shared paper, 2017 · strength 0.06
- Paper MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of… DOI 10.3892/etm.2017.4770 ↗
Yueping Jiang · 1 shared paper, 2017 · strength 0.06
- Paper MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of… DOI 10.3892/etm.2017.4770 ↗
Qinghui Niu · 1 shared paper, 2017 · strength 0.06
- Paper MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of… DOI 10.3892/etm.2017.4770 ↗
Di Xia · 1 shared paper, 2017 · strength 0.06
- Paper MicroRNA-186 affects the proliferation of tumor cells via yes-associated protein 1 in the occurrence and development of… DOI 10.3892/etm.2017.4770 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.